PMID: 16519005Mar 8, 2006Paper

GDNF and addiction

Reviews in the Neurosciences
Dorit Ron, Patricia H Janak

Abstract

Biochemical adaptations to drugs of abuse and alcohol are especially profound in midbrain dopaminergic neurons. Long-lasting molecular and structural changes in mesolimbic dopaminergic neurons that result from chronic exposure to drugs of abuse and alcohol are thought to underlie adverse behaviors such as compulsive drug seeking and relapse. Recent studies suggest that a subset of these changes is prevented/reversed by activation of the glial cell line-derived neurotrophic factor (GDNF) signaling pathway. Behavioral effects of drugs of abuse such as cocaine and alcohol are also negatively regulated by GDNF: inhibition of the endogenous GDNF pathway enhances the activity of drugs of abuse, while administration of GDNF reduces the severity of the effects. In this review, we summarize the data implicating GDNF as a negative regulator of drug and alcohol addiction. We also provide evidence to suggest that therapies that activate GDNF signaling may be useful for the treatment of drug and alcohol addiction.

References

Jan 1, 1992·Life Sciences·H SershenA Lajtha
Jul 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Di Chiara, A Imperato
Jan 1, 1984·Annals of the New York Academy of Sciences·M Goldstein
Oct 1, 1995·Journal of Internal Medicine·A SchuchardtV Pachnis
Nov 16, 1994·Behavioural Brain Research·S L CappendijkM R Dzoljic
Jul 1, 1994·Journal of Substance Abuse Treatment·S G Sheppard
Jan 1, 1994·Pharmacology, Biochemistry, and Behavior·H SershenA Lajtha
Sep 14, 1993·European Journal of Pharmacology·S L Cappendijk, M R Dzoljic
Nov 1, 1995·The Netherlands Journal of Medicine·P J de VriesJ van Hattum
Nov 1, 1995·Pharmacology, Biochemistry, and Behavior·A H RezvaniY W Lee
Jun 27, 1996·Nature·P DurbecM Saarma
Jul 4, 1996·Nature·M W MooreA Rosenthal
Jul 4, 1996·Nature·J J TreanorA Rosenthal
Sep 5, 1996·Brain Research. Molecular Brain Research·C Suter-Crazzolara, K Unsicker
Jan 1, 1996·Advances in Cancer Research·B A Ponder, D Smith
Mar 1, 1997·The European Journal of Neuroscience·N A PochonP Aebischer
Aug 14, 1998·The Journal of Comparative Neurology·J P GoldenE M Johnson
Oct 13, 1998·Neuron·G F KoobF E Bloom
Oct 3, 1999·The American Journal on Addictions·K R AlperJ Bastiaans
Jul 27, 2000·Annals of the New York Academy of Sciences·S D Glick, I M Maisonneuve
Sep 21, 2000·The European Journal of Neuroscience·M J Bourque, L E Trudeau

❮ Previous
Next ❯

Citations

Jun 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Sebastien CarnicellaDorit Ron
Sep 11, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ruben J Boado, William M Pardridge
Jan 16, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Qing-Hui ZhouWilliam M Pardridge
Jan 13, 2010·Journal of Drug Targeting·William M Pardridge
Jul 24, 2012·Pharmacology, Biochemistry, and Behavior·Sarah M ClintonHuda Akil
May 30, 2012·The Psychiatric Clinics of North America·Stephen Ross
Jul 19, 2011·Trends in Neurosciences·Charles L PickensYavin Shaham
Jun 18, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Annemarie HeberleinThomas Hillemacher
Oct 27, 2009·Progress in Neurobiology·Heather A BogerLawrence D Middaugh
Oct 1, 2008·Progress in Neurobiology·Ana SaavedraEmília P Duarte
Nov 22, 2007·Journal of Ethnopharmacology·Kenneth R AlperCharles D Kaplan
May 18, 2016·Neurobiology of Disease·Maryna KoskelaMikko Airavaara
Jul 23, 2016·Frontiers in Behavioral Neuroscience·Mona BuhusiCatalin V Buhusi
Aug 27, 2019·Journal of Behavioral Addictions·Arundhuti DasCsaba Barta
Oct 25, 2017·Neuropsychobiology·Andreia Moreira da Silva SantosKaren M Doyle
Feb 26, 2013·The International Journal of Neuropsychopharmacology·Yijin YanToshitaka Nabeshima
Oct 1, 2020·International Journal of Molecular Sciences·Arun Kumar Mahato, Yulia A Sidorova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.